Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

China flag China · Delayed Price · Currency is CNY
14.33
-0.17 (-1.17%)
Apr 2, 2025, 2:45 PM CST
27.83%
Market Cap 23.43B
Revenue (ttm) 3.88B
Net Income (ttm) -422.97M
Shares Out 1.62B
EPS (ttm) -0.26
PE Ratio n/a
Forward PE 27.36
Dividend 0.10 (0.71%)
Ex-Dividend Date n/a
Volume 7,318,631
Average Volume 12,423,201
Open 14.51
Previous Close 14.50
Day's Range 14.28 - 14.78
52-Week Range 10.45 - 16.01
Beta 0.66
RSI 62.83
Earnings Date Apr 29, 2025

About SHA:603707

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, fulvestrant, doxercalciferol, milrinone lactate, fondaparinux sodium, phenylephrine, gemcitabine, levoleucovorin, carboplatin, cytarabine, bleomycin, topotecan hydrochloride, bendamustine HCL, bortezomib, clofarabine, busulfan, dactinomycin, azacitidine, mycophenolate mofetil, tige... [Read more]

Sector Healthcare
Founded 2000
Employees 1,451
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603707
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.